Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
about
Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets.Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response.Long non-coding RNAs associated with non-small cell lung cancer.LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression.Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma.Role of long non-coding RNA in drug resistance in non-small cell lung cancer.Emerging role of long non-coding RNAs in cisplatin resistance.lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinomaLong non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy
P2860
Q33624398-5D6A4809-251C-4923-B0C2-5EA3B57AC205Q39254523-66A7B7C6-5AB8-4868-9948-6774F5E15F35Q41466279-7E3735E9-4BD7-4075-8678-F8712A8DEE2EQ42366666-BF58CA0E-D076-47D1-A5E7-D2AE6EDE712AQ45722094-EAFF3CE5-5A10-477E-B2E8-751CFA54859AQ47179544-1C384500-6353-45E9-8C60-621926771BACQ48346788-6AA12126-EAE4-4A1B-A1ED-C433E92D297BQ49957676-315C53B9-FCFB-4E4A-BE9B-C2ABCE6CB4F6Q50951234-9F449CA1-2417-46E7-ADF7-F2FE5E66C224Q53687949-FAA5F50A-11AF-4896-98B9-256732D06661Q55172138-AC132B38-BDDD-49EB-B28B-E7DA33BE4296Q57482786-A12D4CB2-FC74-4639-9D06-E0F38B20390BQ59135603-5D61F7E3-C3AE-4AA5-9C18-D48E4EE75BF6
P2860
Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@en
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@nl
type
label
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@en
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@nl
prefLabel
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@en
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Correlation of long non-coding ...... utcome in lung adenocarcinoma.
@en
P2093
Caicun Zhou
Chunxia Su
Limin Zhang
Ningning Cheng
Shengxiang Ren
Weijing Cai
P2860
P304
P356
10.18632/ONCOTARGET.13708
P407
P577
2016-11-29T00:00:00Z